#United States #New York #Acadia Healthcare #SEC Investigation #Faruqi & Faruqi

Deadline Alert: Investigation Launched by Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors affected by substantial financial losses related to Acadia Healthcare Company, Inc. This investigation comes in light of major allegations against Acadia, which claim that the company and its executives may have breached federal securities laws.

Investor Alert

If you experienced losses exceeding $100,000 from your investments in Acadia Healthcare between February 28, 2020, and October 18, 2024, it is crucial to take action. Those impacted are encouraged to contact James (Josh) Wilson, a partner at Faruqi & Faruqi, directly at 877-247-4292 or 212-983-9330 (Ext. 1310) for a consultation regarding your rights as an investor.

The law firm has set a deadline of December 16, 2024, for investors wishing to be considered as lead plaintiffs in a federal class action lawsuit filed against Acadia Healthcare. This case centers around alarming practices that have surfaced regarding the company’s treatment of patients and their billing operations.

Acadia Healthcare Under Scrutiny

Recent revelations, fueled by an investigative article published by The New York Times, highlight frightening claims that Acadia Healthcare has been detaining patients without medical justification. The report underscores the disturbing scenario where individuals were allegedly held against their will, suggesting that the company’s revenue growth might stem from unethical practices during a time of increased demand for mental health services.

Witness statements from multiple states illustrated that patients, law enforcement, and employees have raised concerns about the illegal detention methods used by Acadia Healthcare, prompting judicial interventions in several instances. This troubling backdrop has triggered substantial media attention and raised questions about the company's operational integrity, culminating in a notable drop in Acadia's stock price, which fell 4.5% following the article’s release.

Further compounding the issue, Acadia Healthcare publicly disclosed that it has received requests for information from the U.S. Attorney's Office and a grand jury subpoena associated with its admissions and billing practices as recently as September 2024. This news led to an alarming 16.36% drop in share price, signaling investor panic and chaos over the company’s future.

Importance of Legal Representation

As this investigation unfolds, it’s imperative for investors to understand their rights. The court-appointed lead plaintiff will be a member of the putative class who possesses the largest financial interest in the relief sought and is deemed adequate to represent the interests of the class. Investors who wish to be included should act promptly, whether they choose to pursue the role of lead plaintiff or prefer to remain in an absent class member status.

Faruqi & Faruqi also emphasizes its commitment to supporting whistleblowers, former employees, shareholders, and others with relevant information regarding Acadia Healthcare’s practices. Insights from these individuals can significantly aid the investigation and contribute to achieving justice for all affected investors.

Conclusion

Acadia Healthcare stands at a crucial crossroads as allegations of malpractice and misconduct shape the narrative surrounding the company. Investors facing significant losses are encouraged to leverage the opportunity to discuss their options with experienced legal professionals at Faruqi & Faruqi. The path forward remains fraught with uncertainty, but timely action could enhance the potential for recovery amid these unfolding revelations. To learn more about the Acadia Healthcare class action, visit faruqilaw.com/ACHC or connect with Josh Wilson for direct inquiries.

_Faruqi & Faruqi, LLP is recognized for its pivotal role in securities litigation, having successfully recovered substantial amounts for investors since its establishment in 1995. The firm maintains offices in New York, Pennsylvania, California, and Georgia and prioritizes confidentiality in all communications._